African-Caribbean Cancer Consortium Scientific and Training Conference

描述（由申请人提供）：非洲-加勒比癌症联盟 (AC3) 成立于 2006 年，旨在研究非洲人后裔的病毒、遗传和环境风险因素。该联盟的成立为加勒比地区、美国和非洲各个岛屿的研究人员之间的癌症研究提供了新的合作机会。自 AC3 成立以来，已有 71 名研究人员加入并正在进行美国、加勒比岛屿和非洲癌症风险的合作研究。美国布鲁克林、巴哈马、牙买加、特立尼达和多巴哥、圭亚那以及尼日利亚正在进行宫颈癌和前列腺癌研究。美国（匹兹堡和布鲁克林）正在进行头颈癌研究。布鲁克林、特立尼达和多巴哥、巴巴多斯和圭亚那正在进行乳腺癌研究。研究人群包括非裔美国人、非洲裔加勒比人、非洲人以及居住在美国的非洲裔移民。我们寻求资金来支持我们的下一次会议，题为“继续建设能力以解决非洲裔人群的健康差异：关注女性癌症”。本次会议的目的是提供论坛/基础设施，通过该论坛/基础设施，AC3 参与研究人员和非成员将能够： 1) 展示癌症研究数据和新资助研究的进展报告，或评估关注非洲人后裔的基因-环境相互作用和癌症差异的研究的新研究思路； 2) 描述存在或不存在的可能导致研究人群癌症发病率和死亡率较高的卫生资源、筛查和其他预防活动； 3）正式讨论当前和未来研究合作的协调； 4) 提供一个培训初级研究者和有兴趣从事健康差异研究职业的学生的论坛 5) 提高整个费城当地社区对少数族裔参与研究和临床试验重要性的认识； 6) 向 NIMHD 和 NCI 寻求资金，以支持这些高危人群癌症风险的病例对照研究。即将召开的会议将集中我们的注意力来满足对非洲裔女性癌症相关研究的巨大需求，并将促进填补关于非洲裔女性癌症风险和结果的现有知识空白的研究。该会议还将提供一个培训和职业发展论坛，这将增加年轻癌症研究人员的多样性。这次会议的独特之处在于，它不仅是一个培训、研究报告和互动的论坛，而且还促进涉及非裔美国人、非洲裔加勒比人和整个非洲人口的研究的发展和协调。

DESCRIPTION (provided by applicant): The African-Caribbean Cancer Consortium (AC3) was conceived in 2006 for the study of viral, genetic and environmental risk factors in populations of African descent. The establishment of this Consortium has provided new collaborative opportunities for cancer research among investigators throughout the various islands in the Caribbean, United States and Africa. Since the establishment of the AC3, 71 investigators have joined and are conducting collaborative studies of cancer risk in the US, Caribbean islands and Africa. Cervical and prostate cancer studies are ongoing in Brooklyn, USA, the Bahamas, Jamaica, Trinidad and Tobago, Guyana as well as Nigeria. Head and neck cancer studies are ongoing in the US (Pittsburgh and Brooklyn). Breast cancer studies are ongoing in Brooklyn, Trinidad and Tobago, Barbados and Guyana. The studied populations include African-Americans, African-Caribbean, African as well as immigrant African-descent populations living in the United States. We seek funding to support our next conference entitled: "Continuing to Build Capacity to Address Health Disparities in Populations of African Ancestry: a Focus on Women's Cancers." The purpose of this conference is to provide the forum/infrastructure through which AC3 participating investigators and non-members will be able to 1) present cancer research data and progress reports of newly funded studies or evaluate new research ideas for studies that focus on gene- environment interactions and cancer disparities in populations of African descent; 2) describe the health resources, screening and other preventive activities present or absent that may attribute to higher cancer incidence and mortality in their study populations; 3) to formally discuss the coordination of current and future research collaborations; 4) provide a forum for training junior investigators and students who are interested in pursuing careers in health disparities research 5) raise the awareness throughout the local Philadelphia community about the importance of minority participation research and clinical trials; and 6) to seek funding from the NIMHD and NCI to support case-control studies of cancer risk across these at-risk populations. This upcoming meeting will focus our attention to address a significant need for studies related to cancer in women of African descent and will promote studies that will fill in the gaps in the existing knowledge about cancer risk and outcomes related to women's cancers in African-descent populations. The conference will also provide a forum for training and career development that will lead to an increase in diversity among young cancer research investigators. The uniqueness of this conference is that it serves not only as a forum for training, research presentation and interaction, but also promotes the development and coordination of research studies that involve African-American, African-Caribbean and African populations as a whole.